Search Results 831-840 of 15951 for anti-TNF drugs

1. Clinical trials - Oncology (Medical)

   Clinical trials · Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study · Novel SEQUEnced Immunotherapy With Anti-angiogenesis and ...

2. Publications - Patricio Escalante, M.D., M.S. - Mayo Clinic

   Characteristics and outcomes of anti-mycobacterial therapy compared to no anti-mycobacterial therapy for NTM pulmonary disease. Respir Med. 2022 Jun; 197 ...

3. A Study to Develop the Use of Ultrasound to Monitor Treatment of Crohn's Disease - Mayo Clinic

   The purpose of this study is to compare the effectiveness of ultrasound with magnetic resonance (MR) enterography in the diagnosing and monitoring of Crohn's ...

4. Selinexor Treatment of Refractory Myeloma - Mayo Clinic

   ... anti-CD38 mAb, daratumumab. Refractory is defined as ≤ 25% response to therapy, or progression during therapy or progression within 60 days after ...

5. Clinical trials - Oncology (Medical)

   ... drugs that contain the metal platinum but then comes back within a certain ... anti-CTLA-4 +/- anti-PD-1/PD-L1, and (2) anti-PD-1/PD-L1 +/- chemo ...

6. A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) - Mayo Clinic

   A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) · Share ...

7. Durvalumab and Grid Therapy for the Treatment of Non-small Cell Lung Cancer in Patients Who Progressed During or After Treatment With the PACIFIC Regimen - Mayo Clinic

   The purpose of this study is to determine whether combining grid therapy at the time of disease progression during durvalumab administration or shortly after ...

8. A Study to Evaluate the Safety and Effectiveness of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients - Mayo Clinic

   Participation eligibility · Subjects who received anticancer therapy or investigational drug within 28 days of first dose. · Subjects who received any approved ...

9. A Study to Evaluate CPI-006 with Standard of Care vs. Placebo with Standard of Care in Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling by Invitation Only) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Receipt of cancer chemotherapy or immunomodulatory drugs including ( ...

10. Publications - Zelalem Temesgen, M.D. - Mayo Clinic

    Anti-gm-csf monoclonal antibody treatment of ... Early switch to oral antibiotic therapy for the treatment ... Novel HIV drugs and drug delivery strategies. A ...